Stock Market & Financial Investment News

News Breaks October 24, 2012 07:33 EDT BMY Bristol-Myers reports Q3 adjusted EPS 41c, consensus 42c Reports Q3 revenue $3.74B consensus $3.98B. News For BMY From The Last 14 Days Check below for free stories on BMY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. 1 | 2 | all recent BMY news | >> May 23, 2013 06:02 EDT BMY Bristol-Myers implied volatility at upper end of index mean range 05:47 EDT BMY Stocks with implied volatility movement; SKS BMY Stocks with implied volatility movement; Saks (SKS), Bristol-Myers (BMY) according to IVolatility. May 22, 2013 16:00 EDT BMY Options Update; May 22, 2013 Subscribe for More Information 10:33 EDT BMY Bristol-Myers jumps after Citi ups rating on cancer potential Subscribe for More Information 10:16 EDT BMY Bristol-Myers spikes higher following upgrade, levels to watch Subscribe for More Information 10:00 EDT BMY On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:05 EDT BMY Bristol-Myers upgraded to Buy from Neutral at Citigroup Subscribe for More Information May 21, 2013 07:34 EDT BMY UBS to host a conference Subscribe for More Information 07:24 EDT BMY Global Health Care to host a conference Subscribe for More Information May 20, 2013 10:03 EDT BMY Shire advances after report renews takeover speculation Subscribe for More Information 06:30 EDT BMY Leerink estimates Shire takeout value at least $110 per share Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. 06:25 EDT BMY Shire may return cash to thwart takeover, Daily Mail reports Subscribe for More Information May 17, 2013 13:21 EDT BMY Options with increasing implied volatility: CPRT BMY GDI HNZ Subscribe for More Information May 16, 2013 16:32 EDT BMY Bristol-Myers announces intention to voluntarily delist preferred stock Subscribe for More Information 13:20 EDT BMY Follow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares. 13:14 EDT BMY Bristol-Myers upgraded to Outperform from Market Perform at Leerink Subscribe for More Information 08:55 EDT BMY BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call Subscribe for More Information 08:38 EDT BMY Bristol-Myers shares likely to give back recent gains, says Leerink Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers. 05:52 EDT BMY Stocks with implied volatility movement; BMY SLV Subscribe for More Information May 15, 2013 11:28 EDT BMY Options with increasing implied volatility: BMY AGNC EBIX IAU Subscribe for More Information 1 | 2 | all recent BMY news | >> Sign up for a free trial to see the rest of the stories you've been missing.